BSECompany Update1d ago · 26 Oct 2026, 06:23 pm
Conference call for Analysts and Investors to discuss the un-audited financial results of the Company for the quarter and half year ended September 30, 2026 on Tuesday, November 03, 2026 at 04:00 p.m. (IST)
Advanced Enzyme Technologies Ltd · 540025
✦ AI SummaryResults
Advanced Enzyme Technologies Ltd will host a conference call on November 3, 2026, to discuss its un-audited financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
c16ccedc-ef75-4164-9dac-a8c85f146ff6.pdf
View document text
cfrancec/ enzymes
WhoreENZYMEisLife
AdvancedEnzymeTechnologiesLtd.
CIN:L24200MH1989PLC051018
SunMagnetica,Awing,5thFloor,LICServiceRoad,Louiswadi,Thane(W)-400604,India
Tel:+91-22-41703200,Fax:+91-22-25835159
Email:info@advancedenzvmes.
com,
www.advancedenzymes.
October 26, 2026
BSE Limited National Stock Exchange of India Ltd.
Department of Corporate Affairs Exchange Plaza, Plot No. C/1, G Block
P. J. Towers, Dalal Street, Bandra-Kurla Complex, Bandra (E)
Mumbai- 400 001 Mumbai- 400 051
Scrip ID-540025 Scrip Code-ADVENZYMES
Dear Sir,
Sub: Intimation of conference call to discuss Un-audited Financial Results for the
quarter and half year ended September 30, 2026 under the SEBI (Listing Obligations and
Disclosure Requirements) Regulations
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015 (as amended), we would like to inform that
the Company will host a conference call for Analysts and Investors to discuss the un-audited
financial results of the Company for the quarter and half year ended September 30, 2026 on
Tuesday, November 03, 2026 at 04:00 p.m. (IST) as per the details provided in the Annexure.
The aforesaid information is also being uploaded on the website of the Company.
Thanking you,
Yours Faithfully,
For Advanced Enzyme Technologies Limited
Sanjay Basantani
Company Secretary and Head – Legal
Encl.: As above
Factory:PlotNo.A-61/62,MIDCMalegaon,Tal.Sinnar,Dist.Nashik-422113.Maharashtra.India.Tel.:+91-9970100750/+91-2551-230044,Fax:+91-2551-230816
Mancecl enzymes
WhereENZYMEisLite
MANAGEMENTWILLBEREPRESENTEDBY:
Advanced Enzyme Technologies Limited
Mr.MukundKabra Mr.Beni Prasad Rauka
Whole-timeDirector ChiefFinancialOfficer
willhost a conference call for analysts andinvestors
to discussthe financial resultsfor theQuarter & Half
year ended 30th September 2026 CONFERENCEDIAL-INNUMBERS
Please dialthenumbers at least 5 -10minutesprior tothe
conferencescheduleto ensurethat youareconnectedto your
Tuesday 16:00 callintime
03rdNovember 2026 Hours 1ST
Primary Number:+91 22 6280 1403 / +91 22 7115 8304
USA:18667462133|UK:08081011573|Singapore:8001012045
HongKong: 800964448 | Canada:01180014243444
Pre-register to
REGISTRATIONLINK
avoid wait time:
RSVP AdvancedEnzymeTechnologiesLimited
£ AdvancedEnzymeTechnologiesLimited Q Regd.Office:5thFloor,'A'Wing,SunMagnetica,Louiswadi,
Mr. Ronak Saraf | Investor Relations Thane(W)- 400604 | Tel.:+912241703200
S.3 ir@advancedenzymes. com (fy Website:www.advancedenzymes.com
V +918657864146 ala CINNo:L24200MH1989PLC051018